Newly approved drug is a “game changer” for Stage 4 pancreatic cancer patients Central Oregon DailyFDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease WSJOnco360® Has Been Selected as a National Pharmacy Partner for RASONQUE™ (daraxonrasib) Yahoo! Finance CanadaFDA approves breakthrough drug daraxonrasib to treat pancreatic cancer BBCFDA Approves RevMed’s Breakthrough Pill for Pancreatic Cancer Bloomberg.com